VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)

Inclusion Criteria: * Able to read (or, if unable to read due to visual impairment, be read to verbatim by the person administering the informed consent form or a family member) and understand the informed consent form and willing to sign the informed consent form * Signed informed consent form. In Japan only, the informed consent form for a subject under the age of 20 years will require the co-signature of the subject's legally authorized representative. * Men and women ≥ 18 years of age * Myopia of greater than or equal to -6 D OR axial length of greater than or equal to 26.5 mm * Active subfoveal or juxtafoveal (within 1 to 199 μm of the center of the fovea) CNV secondary to pathologic myopia as defined by leakage on FA * Best-corrected visual acuity of 73 to 35 letters (ETDRS equivalent of 20/40 to 20/200) in the study eye at 4 meters * Decrease in vision in the study eye is determined by the investigator, using his/her medical judgment, to be primarily the result of the current active mCNV * Willing, committed, and able to return for all clinic visits and complete all study-related procedures Exclusion Criteria: * Only one functional eye * Ocular media of insufficient quality to obtain fundus and OCT images in the study eye * Greatest linear dimension (GLD) of the lesion in the study eye is greater than 12 disc areas * Recurrent mCNV in the study eye * Aphakia in the study eye * History or presence of CNV with an origin other than pathologic myopia in the study eye * …